99 related articles for article (PubMed ID: 16920344)
1. Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components.
Kelber O; Wittwer A; Lapke C; Kroll U; Weiser D; Okpanyi SN; Heilmann J
Phytomedicine; 2006; 13 Suppl 5():107-13. PubMed ID: 16920344
[TBL] [Abstract][Full Text] [Related]
2. Binding of STW 5 (Iberogast) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors.
Simmen U; Kelber O; Okpanyi SN; Jaeggi R; Bueter B; Weiser D
Phytomedicine; 2006; 13 Suppl 5():51-5. PubMed ID: 16973340
[TBL] [Abstract][Full Text] [Related]
3. The active components and the pharmacological multi-target principle of STW 5 (Iberogast).
Wegener T; Wagner H
Phytomedicine; 2006; 13 Suppl 5():20-35. PubMed ID: 16926095
[TBL] [Abstract][Full Text] [Related]
4. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.
Ammon HP; Kelber O; Okpanyi SN
Phytomedicine; 2006; 13 Suppl 5():67-74. PubMed ID: 16978852
[TBL] [Abstract][Full Text] [Related]
5. STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine.
Müller MH; Liu CY; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
Phytomedicine; 2006; 13 Suppl 5():100-6. PubMed ID: 16713220
[TBL] [Abstract][Full Text] [Related]
6. Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
Schemann M; Michel K; Zeller F; Hohenester B; Rühl A
Phytomedicine; 2006; 13 Suppl 5():90-9. PubMed ID: 16765572
[TBL] [Abstract][Full Text] [Related]
7. STW 5 (Iberogast) and its individual herbal components modulate intestinal electrophysiology of mice.
Sibaev A; Yuece B; Kelber O; Weiser D; Schirra J; Göke B; Allescher HD; Storr M
Phytomedicine; 2006; 13 Suppl 5():80-9. PubMed ID: 16713219
[TBL] [Abstract][Full Text] [Related]
8. Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components.
Schempp H; Weiser D; Kelber O; Elstner EF
Phytomedicine; 2006; 13 Suppl 5():36-44. PubMed ID: 16777393
[TBL] [Abstract][Full Text] [Related]
9. The herbal preparation STW 5 (Iberogast) desensitizes intestinal afferents in the rat small intestine.
Liu CY; Müller MH; Glatzle J; Weiser D; Kelber O; Enck P; Grundy D; Kreis ME
Neurogastroenterol Motil; 2004 Dec; 16(6):759-64. PubMed ID: 15601426
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6.
Michael S; Kelber O; Hauschildt S; Spanel-Borowski K; Nieber K
Phytomedicine; 2009 Mar; 16(2-3):161-71. PubMed ID: 19196500
[TBL] [Abstract][Full Text] [Related]
11. The multi-herbal drug STW 5 (Iberogast) has prosecretory action in the human intestine.
Krueger D; Gruber L; Buhner S; Zeller F; Langer R; Seidl S; Michel K; Schemann M
Neurogastroenterol Motil; 2009 Nov; 21(11):1203-e110. PubMed ID: 19210628
[TBL] [Abstract][Full Text] [Related]
12. Intestinal spasmolytic effects of STW 5 (Iberogast) and its components.
Heinle H; Hagelauer D; Pascht U; Kelber O; Weiser D
Phytomedicine; 2006; 13 Suppl 5():75-9. PubMed ID: 16709451
[TBL] [Abstract][Full Text] [Related]
13. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
[TBL] [Abstract][Full Text] [Related]
14. Intestinal absorption of hawthorn flavonoids--in vitro, in situ and in vivo correlations.
Zuo Z; Zhang L; Zhou L; Chang Q; Chow M
Life Sci; 2006 Nov; 79(26):2455-62. PubMed ID: 16989871
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical prerequisites for a multi-target therapy.
Kroll U; Cordes C
Phytomedicine; 2006; 13 Suppl 5():12-9. PubMed ID: 16857355
[TBL] [Abstract][Full Text] [Related]
16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
17. Effect of chito-oligosaccharide on the intestinal absorptions of phenylethanoid glycosides in Fructus Forsythiae extract.
Zhou W; Tan X; Shan J; Liu T; Cai B; Di L
Phytomedicine; 2014 Oct; 21(12):1549-58. PubMed ID: 25442264
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of muscular spasm-induced pain of Guangtongxiao recipe in a non-everted gut sac in vitro model.
Deng Z; Weng X; Zhao Y; Gao J; Yu D
J Ethnopharmacol; 2020 Oct; 260():113040. PubMed ID: 32492495
[TBL] [Abstract][Full Text] [Related]
19. [In situ rats single pass perfusion intestinal absorption of the effectivein components in Radix Angelicae Pubescentis].
Wu YN; Luan LB
Yao Xue Xue Bao; 2008 Jan; 43(1):102-7. PubMed ID: 18357742
[TBL] [Abstract][Full Text] [Related]
20. Antioxidative properties of the gastrointestinal phytopharmaceutical remedy STW 5 (Iberogast).
Germann I; Hagelauer D; Kelber O; Vinson B; Laufer S; Weiser D; Heinle H
Phytomedicine; 2006; 13 Suppl 5():45-50. PubMed ID: 16713223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
